SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    S. Kanai, K. Ishihara, E. Kawashita, T. Tomoo, K. Nagahira, Y. Hayashi, S. Akiba, ASB14780, an Orally Active Inhibitor of Group IVA Phospholipase A2, Is a Pharmacotherapeutic Candidate for Nonalcoholic Fatty Liver Disease, Journal of Pharmacology and Experimental Therapeutics, 2016, 356, 3, 604

    CrossRef

  2. 2
    Mi-Ok Sim, Hae-In Lee, Ju Ri Ham, Kwon-Il Seo, Myung-Joo Kim, Mi-Kyung Lee, Anti-inflammatory and antioxidant effects of umbelliferone in chronic alcohol-fed rats, Nutrition Research and Practice, 2015, 9, 4, 364

    CrossRef

  3. 3
    Catriona Crossan, Emmanuel A Tsochatzis, Louise Longworth, Kurinchi Gurusamy, Brian Davidson, Manuel Rodríguez-Perálvarez, Konstantinos Mantzoukis, Julia O’Brien, Evangelos Thalassinos, Vassilios Papastergiou, Andrew Burroughs, Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation, Health Technology Assessment, 2015, 19, 9, 1

    CrossRef

  4. 4
    Gabriel Barros Rodrigues, Sura Wanessa Santos Rocha, Laise Aline Martins dos Santos, Wilma Helena Oliveira, Fabiana Oliveira dos Santos Gomes, Maria Eduarda da Rocha França, Deniele Bezerra Lós, Christina Alves Peixoto, Diethylcarbamazine: Possible therapeutic alternative in the treatment of alcoholic liver disease in C57BL/6 mice, Clinical and Experimental Pharmacology and Physiology, 2015, 42, 4
  5. 5
    Reza Heidari, Hossein Niknahad, Akram Jamshidzadeh, Narges Abdoli, Factors affecting drug-induced liver injury: antithyroid drugs as instances, Clinical and Molecular Hepatology, 2014, 20, 3, 237

    CrossRef

  6. 6
    Mark A. Barnes, Sanjoy Roychowdhury, Laura E. Nagy, Innate immunity and cell death in alcoholic liver disease: Role of cytochrome P4502E1, Redox Biology, 2014, 2, 929

    CrossRef

  7. 7
    B.E. Oyinloye, S.O. Nwozo, G.H. Amah, A.O. Awoyinka, O.A Ojo, B.O. Ajiboye, H.A. Tijani, Prophylactic effect of aqueous extract ofSesamum indicumseeds on ethanol-induced toxicity in male rats, Nutrition Research and Practice, 2014, 8, 1, 54

    CrossRef

  8. 8
    LQ Liu, ZQ Fan, YF Tang, ZJ Ke, The Resveratrol Attenuates Ethanol-Induced Hepatocyte Apoptosis Via Inhibiting ER-Related Caspase-12 Activation and PDE Activity In Vitro, Alcoholism: Clinical and Experimental Research, 2014, 38, 3
  9. 9
    Fatiha Aliche-Djoudi, Normand Podechard, Aurore Collin, Martine Chevanne, Emilie Provost, Martine Poul, Ludovic Le Hégarat, Daniel Catheline, Philippe Legrand, Marie-Thérèse Dimanche-Boitrel, Dominique Lagadic-Gossmann, Odile Sergent, A role for lipid rafts in the protection afforded by docosahexaenoic acid against ethanol toxicity in primary rat hepatocytes, Food and Chemical Toxicology, 2013, 60, 286

    CrossRef

  10. 10
    David A. DeSantis, Chih-wei Ko, Yang Liu, Xiuli Liu, Amy G. Hise, Gabriel Nunez, Colleen M. Croniger, Alcohol-Induced Liver Injury Is Modulated by Nlrp3 and Nlrc4 Inflammasomes in Mice, Mediators of Inflammation, 2013, 2013, 1

    CrossRef

  11. 11
    Ho-Young Park, Hee-Don Choi, Hyojin Eom, Inwook Choi, Enzymatic modification enhances the protective activity of citrus flavonoids against alcohol-induced liver disease, Food Chemistry, 2013, 139, 1-4, 231

    CrossRef

  12. 12
    Trivia P. Frazier, Jeffrey M. Gimble, Indu Kheterpal, Brian G. Rowan, Impact of low oxygen on the secretome of human adipose-derived stromal/stem cell primary cultures, Biochimie, 2013, 95, 12, 2286

    CrossRef

  13. 13
    Mark A. Barnes, Megan R. McMullen, Sanjoy Roychowdhury, Sorana G. Pisano, Xiuli Liu, Abram B. Stavitsky, Richard Bucala, Laura E. Nagy, Macrophage migration inhibitory factor contributes to ethanol-induced liver injury by mediating cell injury, steatohepatitis, and steatosis, Hepatology, 2013, 57, 5
  14. 14
    Marshall J. Orloff, Jon I. Isenberg, Henry O. Wheeler, Kevin S. Haynes, Horacio Jinich-Brook, Roderick Rapier, Florin Vaida, Robert J. Hye, Susan L. Orloff, Alcoholic Versus Nonalcoholic Cirrhosis in a Randomized Controlled Trial of Emergency Therapy of Bleeding Varices, Journal of Surgical Research, 2012, 174, 1, 98

    CrossRef

  15. 15
    K. Muffak-Granero, C. Olmedo, F. Garcia-Alcalde, A. Comino, T. Villegas, J.M. Villar, D. Garrote, A. Blanco, P. Bueno, J.-A. Ferron, Gene Network Profiling Before and After Transplantation in Alcoholic Cirrhosis Liver Transplant Recipients, Transplantation Proceedings, 2012, 44, 6, 1493

    CrossRef

  16. 16
    Xiaobing Dou, Songtao Li, Zhigang Wang, Dongfang Gu, Chen Shen, Tong Yao, Zhenyuan Song, Inhibition of NF-κB Activation by 4-Hydroxynonenal Contributes to Liver Injury in a Mouse Model of Alcoholic Liver Disease, The American Journal of Pathology, 2012, 181, 5, 1702

    CrossRef

  17. 17
    Rebecca M Lovell, Alexander C Ford, Prevalence of Gastro-Esophageal Reflux-Type Symptoms in Individuals With Irritable Bowel Syndrome in the Community: A Meta-Analysis, The American Journal of Gastroenterology, 2012, 107, 12, 1793

    CrossRef

  18. 18
    Rajeshwar P. Mookerjee, Rajiv Jalan, Reply to: “Is a liver biopsy necessary in alcoholic hepatitis?”, Journal of Hepatology, 2012, 56, 6, 1428

    CrossRef

  19. 19
    José Altamirano, Ramón Bataller, Alcoholic liver disease: pathogenesis and new targets for therapy, Nature Reviews Gastroenterology & Hepatology, 2011, 8, 9, 491

    CrossRef

  20. 20
    Fei Wang, Bing-Yuan Wang, Corticosteroids or non-corticosteroids: a fresh perspective on alcoholic hepatitis treatment, Hepatobiliary & Pancreatic Diseases International, 2011, 10, 5, 458

    CrossRef

  21. 21
    Sang Min Kim, Kyungsu Kang, Je-Seung Jeon, Eun Hye Jho, Chul Young Kim, Chu Won Nho, Byung-Hun Um, Isolation of Phlorotannins from Eisenia bicyclis and Their Hepatoprotective Effect against Oxidative Stress Induced by tert-Butyl Hyperoxide, Applied Biochemistry and Biotechnology, 2011, 165, 5-6, 1296

    CrossRef

  22. 22
    Nilanjan Ghosh, Rituparna Ghosh, Vivekananda Mandal, Subhash C. Mandal, Recent advances in herbal medicine for treatment of liver diseases, Pharmaceutical Biology, 2011, 49, 9, 970

    CrossRef

  23. 23
    Chao Ye, Wen-yuan Li, Ming-hua Zheng, Yong-ping Chen, T-helper 17 cell: A distinctive cell in liver diseases, Hepatology Research, 2011, 41, 1
  24. 24
    Rajeshwar P. Mookerjee, Caroline Lackner, Rudolf Stauber, Vanessa Stadlbauer, Moesha Deheragoda, Ariane Aigelsreiter, Rajiv Jalan, The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis, Journal of Hepatology, 2011, 55, 5, 1103

    CrossRef

  25. 25
    Christophe Moreno, Philippe Langlet, Axel Hittelet, Luc Lasser, Delphine Degré, Sylvie Evrard, Isabelle Colle, Arnaud Lemmers, Jacques Devière, Olivier Le Moine, Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: A randomized multicenter controlled trial, Journal of Hepatology, 2010, 53, 6, 1117

    CrossRef

  26. 26
    Rebecca Dawber, Workforce redesign utilising advanced practice to improve the lifestyle and cognitive function of patients with alcohol-related brain damage, The Journal of Mental Health Training, Education and Practice, 2010, 5, 3, 31

    CrossRef

  27. 27
    Suchittra Samuhasaneeto, Duangporn Thong-Ngam, Onanong Kulaputana, Doungsamon Suyasunanont, Naruemon Klaikeaw, Curcumin Decreased Oxidative Stress, Inhibited NF-κB Activation, and Improved Liver Pathology in Ethanol-Induced Liver Injury in Rats, Journal of Biomedicine and Biotechnology, 2009, 2009, 1

    CrossRef

  28. 28
    Alexandre Louvet, Faustine Wartel, Hélène Castel, Sébastien Dharancy, Antoine Hollebecque, Valérie Canva–Delcambre, Pierre Deltenre, Philippe Mathurin, Infection in Patients With Severe Alcoholic Hepatitis Treated With Steroids: Early Response to Therapy Is the Key Factor, Gastroenterology, 2009, 137, 2, 541

    CrossRef

  29. 29
    Arnaud Lemmers, Christophe Moreno, Thierry Gustot, Raphaël Maréchal, Delphine Degré, Pieter Demetter, Patricia de Nadai, Albert Geerts, Eric Quertinmont, Vincent Vercruysse, Olivier Le Moine, Jacques Devière, The interleukin-17 pathway is involved in human alcoholic liver disease, Hepatology, 2009, 49, 2
  30. 30
    Marlene Dominguez, Diego Rincón, Juan G. Abraldes, Rosa Miquel, Jordi Colmenero, Pablo Bellot, Joan-Carles García-Pagán, Rosamelia Fernández, Montserrat Moreno, Rafael Bañares, Vicente Arroyo, Joan Caballería, Pere Ginès, Ramón Bataller, A New Scoring System for Prognostic Stratification of Patients With Alcoholic Hepatitis, The American Journal of Gastroenterology, 2008, 103, 11, 2747

    CrossRef

  31. 31
    R D Mayfield, R A Harris, M A Schuckit, Genetic factors influencing alcohol dependence, British Journal of Pharmacology, 2008, 154, 2
  32. 32
    Michael R. Lucey, Bernard L. Silverman, Ari Illeperuma, Charles P. O’Brien, Hepatic Safety of Once-Monthly Injectable Extended-Release Naltrexone Administered to Actively Drinking Alcoholics, Alcoholism: Clinical and Experimental Research, 2008, 32, 3
  33. 33
    Sudheer K. Mantena, Adrienne L. King, Kelly K. Andringa, Heather B. Eccleston, Shannon M. Bailey, Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases, Free Radical Biology and Medicine, 2008, 44, 7, 1259

    CrossRef

  34. 34
    Arvind S. Negi, J.K. Kumar, Suaib Luqman, Karuna Shanker, M.M. Gupta, S.P.S. Khanuja, Recent advances in plant hepatoprotectives: A chemical and biological profile of some important leads, Medicinal Research Reviews, 2008, 28, 5
  35. 35
    J. C. GARCIA-PAGAN, A. DE GOTTARDI, J. BOSCH, Review article: the modern management of portal hypertension – primary and secondary prophylaxis of variceal bleeding in cirrhotic patients, Alimentary Pharmacology & Therapeutics, 2008, 28, 2
  36. 36
    C. D. ZOIS, G. H. BALTAYIANNIS, P. KARAYIANNIS, E. V. TSIANOS, Systematic review: hepatic fibrosis – regression with therapy, Alimentary Pharmacology & Therapeutics, 2008, 28, 10
  37. 37
    Jianwen Liu, Joanne M. Lewohl, R. Adron Harris, Peter R. Dodd, R. Dayne Mayfield, Altered Gene Expression Profiles in the Frontal Cortex of Cirrhotic Alcoholics, Alcoholism: Clinical and Experimental Research, 2007, 31, 9
  38. 38
    Rajeshwar P. Mookerjee, Mohammed Malaki, Nathan A. Davies, Stephen J. Hodges, R. Neil Dalton, Charles Turner, Sambit Sen, Roger Williams, James Leiper, Patrick Vallance, Rajiv Jalan, Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis, Hepatology, 2007, 45, 1
  39. 39
    Full-Young Chang, Ching-Liang Lu, Irritable bowel syndrome in the 21st century: Perspectives from Asia or South-east Asia, Journal of Gastroenterology and Hepatology, 2007, 22, 1
  40. 40
    Herbert Tilg, Christopher P Day, Management strategies in alcoholic liver disease, Nature Clinical Practice Gastroenterology & Hepatology, 2007, 4, 1, 24

    CrossRef

  41. 41
    H. Everitt, V. B. Patel, I. Tewfik, Nutrition and alcoholic liver disease, Nutrition Bulletin, 2007, 32, 2
  42. 42
    H.L. WANG, E.M. BRUNT, Surgery of the Liver, Biliary Tract and Pancreas, 2007,

    CrossRef

  43. 43
    Yong-Han Paik, Alcohol Abuse Related Medical Complications and Treatment, Journal of the Korean Medical Association, 2006, 49, 2, 114

    CrossRef

  44. 44
    Felice Nava, Stefania Premi, Ezio Manzato, Alfio Lucchini, Comparing Treatments of Alcoholism on Craving and Biochemical Measures of Alcohol Consumptions, Journal of Psychoactive Drugs, 2006, 38, 3, 211

    CrossRef

  45. 45
    J.M. Mora, R. Olmedo, E. Curiel, J. Muñoz, M. Herrera, G. Séller, MARS (molecular adsorbent recirculating system) como asistencia extracorpórea hepática en el fracaso hepático agudo grave de etiología enólica, Medicina Intensiva, 2006, 30, 8, 402

    CrossRef

  46. 46
    A. GRAMENZI, F. CAPUTO, M. BISELLI, F. KURIA, E. LOGGI, P. ANDREONE, M. BERNARDI, Review article: alcoholic liver disease – pathophysiological aspects and risk factors, Alimentary Pharmacology & Therapeutics, 2006, 24, 8
  47. 47
    Dominique Thabut, Sylvie Naveau, Frederic Charlotte, Julien Massard, Vlad Ratziu, Françoise Imbert-Bismut, Dominique Cazals-Hatem, Annie Abella, Djamila Messous, Fabienne Beuzen, Mona Munteanu, Julien Taieb, Richard Moreau, Didier Lebrec, Thierry Poynard, The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease, Journal of Hepatology, 2006, 44, 6, 1175

    CrossRef

  48. 48
    Rowen K. Zetterman, Liver Transplantation for Alcoholic Liver Disease, Clinics in Liver Disease, 2005, 9, 1, 171

    CrossRef

  49. 49
    Patrizia Burra, Michael R. Lucey, Liver transplantation in alcoholic patients, Transplant International, 2005, 18, 5
  50. 50
    Philip W. Pemberton, Alexander Smith, Thomas W. Warnes, Non-invasive monitoring of oxidant stress in alcoholic liver disease, Scandinavian Journal of Gastroenterology, 2005, 40, 9, 1102

    CrossRef

  51. 51
    Larry D. Scott, Treatment of Hepatitis C in Injection Drug Users, The American Journal of Gastroenterology, 2005, 100, 1, 5

    CrossRef

  52. 52
    ROBERT M. WEINRIEB, MICHAEL R. LUCEY, Transplantation of the Liver, 2005,

    CrossRef

  53. 53
    Helga Paula, Vijay Shah, Alcoholic Liver Disease,
  54. 54
    Margaret-Mary G. Wilson, Liver and Gall Bladder,
  55. 55
    Norma C. McAvoy, Peter C. Hayes, Portal Hypertension: A Management Problem,